CBZ.NYSECbiz, INC

8-K: CBIZ Reports Strong Q3 Revenue Growth, Marcum Synergies

Sentiment:

Quarterly Results


CBIZ, Inc. announced robust third-quarter and nine-month 2025 financial results, driven by significant revenue growth and better-than-expected synergies from the Marcum acquisition.

Summary

  • Total revenue for the third quarter of 2025 was $693.8 million, an increase of 58.1% compared to $438.9 million in the same period of 2024.
  • Net income for Q3 2025 was $30.1 million, a decrease of 14.1% from $35.1 million in Q3 2024.
  • GAAP diluted earnings per share (EPS) for Q3 2025 was $0.48, down 31.4% from $0.70 in Q3 2024.
  • Adjusted EBITDA for Q3 2025 was $120.0 million, up 57.4% from $76.3 million in Q3 2024.
  • Adjusted diluted EPS for Q3 2025 was $1.01, an increase of 8.5% from $0.93 in Q3 2024.
  • Total revenue for the nine months ended September 30, 2025, was $2.2 billion, an increase of 63.7% compared to $1.35 billion in the same period of 2024.
  • Net income for the nine months ended September 30, 2025, was $194.9 million, up 47.9% from $131.8 million in the prior year period.
  • GAAP diluted EPS for the nine months ended September 30, 2025, was $3.06, up 16.8% from $2.62 in the prior year period.
  • Adjusted EBITDA for the nine months ended September 30, 2025, was $475.6 million, up 92.9% from $246.5 million in the prior year period.
  • Adjusted diluted EPS for the nine months ended September 30, 2025, was $4.27, an increase of 35.6% from $3.15 in the prior year period.
  • Financial Services revenue for Q3 2025 was $578.5 million, significantly up from $322.3 million in Q3 2024.
  • Benefits and Insurance Services revenue for Q3 2025 was $103.4 million, a slight decrease from $104.0 million in Q3 2024.
  • A $12.5 million gain from a legal settlement was recorded during the nine months ended September 30, 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong revenue and adjusted EBITDA growth, with the CEO highlighting better-than-expected synergies from the Marcum acquisition and solid performance in core businesses. However, GAAP net income and EPS declined in the quarter, and interest expenses significantly increased, alongside a rise in Days Sales Outstanding and debt-to-equity ratio, indicating some financial pressures despite overall growth.

Positives

  • Total revenue increased significantly by 58.1% in Q3 2025 and 63.7% for the nine months ended September 30, 2025.
  • Adjusted EBITDA showed robust growth of 57.4% in Q3 2025 and 92.9% for the nine months ended September 30, 2025.
  • Adjusted diluted EPS increased by 8.5% in Q3 2025 and 35.6% for the nine months ended September 30, 2025.
  • Core, recurring essential businesses continued to perform well, and improved market conditions boosted non-recurring businesses.
  • The Marcum acquisition is showing strong validation, including better than expected synergies.
  • The company is well-positioned to drive sustainable long-term growth in the high-growth U.S. middle market.
  • A $12.5 million gain from a legal settlement was recorded during the nine months ended September 30, 2025.

Negatives

  • GAAP Net Income decreased by 14.1% to $30.1 million in Q3 2025 compared to $35.1 million in Q3 2024.
  • GAAP diluted EPS decreased by 31.4% to $0.48 in Q3 2025 compared to $0.70 in Q3 2024.
  • Interest expense significantly increased to $27.96 million in Q3 2025 from $4.97 million in Q3 2024, and to $80.98 million for the nine months ended September 30, 2025, from $15.36 million in the prior year period.
  • Gross margin as a percentage of revenue decreased to 13.0% in Q3 2025 from 16.6% in Q3 2024.
  • Operating income as a percentage of revenue decreased to 8.5% in Q3 2025 from 11.3% in Q3 2024.
  • Days Sales Outstanding (DSO) increased to 94 days at September 30, 2025, from 73 days at December 31, 2024.
  • Benefits and Insurance Services revenue slightly decreased to $103.4 million in Q3 2025 from $104.0 million in Q3 2024.
  • Total long-term debt, net, increased to $1,502.6 million at September 30, 2025, from $1,333.8 million at December 31, 2024.
  • Debt to equity ratio increased to 83.8% at September 30, 2025, from 78.6% at December 31, 2024.

Risks

  • Payments on accounts receivable may be slower than expected, or amounts due on receivables or notes may not be fully collectible.
  • The business could be adversely affected if Marcum LLP does not perform to expectations or if assumed liabilities are underestimated.
  • Dependence on the services of executive officers and other key employees, the loss of whom may have a material adverse effect on the business.
  • Restrictions imposed by independence requirements and conflict of interest rules limit the ability to provide services to clients of attest firms.
  • Goodwill and other intangible assets could become impaired, leading to material non-cash charges against earnings.
  • Certain liabilities resulting from acquisitions are estimated and could lead to a material impact on results of operations.
  • Failure to realize the anticipated benefits of acquisitions, or acquisitions proving disruptive and failing to meet expectations.
  • Recent Securities & Exchange Commission (SEC) and Public Company Accounting Oversight Board sanctions against Marcum may adversely impact performance and reputation.
  • Inability to implement and maintain effective internal control over financial reporting following the Marcum acquisition.
  • Inability to acquire and finance additional businesses, which could limit the ability to pursue business strategy.
  • Incurrence of transaction, integration, and restructuring costs in connection with the acquisition program.
  • Governmental regulations and interpretations are subject to changes, which could have a material adverse effect on financial condition.
  • Continuing uncertainty in the current economic and geopolitical environment could lead to continuing softness in demand for certain services.
  • Changes in the United States healthcare environment, including new healthcare legislation, may adversely affect revenue and margins in the healthcare benefit business.
  • Risks relating to processing customer transactions for payroll and other transaction processing businesses.
  • Cyberattacks or other security breaches involving computer systems or the systems of vendors could materially and adversely affect the business.
  • Reliance on software licensed from third parties.
  • Reliance on information processing systems; any failure or disruptions of these systems could have a material adverse effect.
  • Could be held liable for errors and omissions.
  • The business services industry is competitive and fragmented; inability to compete effectively could negatively impact the business.
  • Tax rate may vary significantly depending on stock price due to levels of share-based compensation.
  • Rapid technological changes could significantly impact competitive position, client relationships, and operating results.
  • Climate change legislation or regulations restricting emissions of greenhouse gases could result in increased operating costs.
  • The adverse impact of legislative and regulatory changes in the U.S. and globally, including as a result of the One Big Beautiful Bill Act, on the tax rate, accounting practices, operations, and results.
  • The widespread outbreak of a communicable illness or any other public health crisis could adversely affect the business.
  • Requires a significant amount of cash for interest payments on debt and to expand the business as planned.
  • Terms of the amended and restated credit agreement providing for $2.0 billion in senior secured credit facilities could adversely affect the ability to run the business and/or reduce stockholder returns.
  • Failure to satisfy covenants in debt instruments could cause a default under those instruments.
  • Increased leverage following the Marcum acquisition may adversely impact the business.
  • May be more sensitive to revenue fluctuations than other companies, which could result in fluctuations in the market price of common stock.
  • The significant number of shares issuable as stock consideration in the Marcum acquisition may adversely impact stock price.
  • The future issuance of additional shares could adversely affect the price of common stock.
  • Volatility in stock price.
  • The price of common stock could be adversely impacted if performance expectations are not met following the Marcum acquisition.

Future Outlook

CBIZ expects full-year 2025 total revenue within a range of $2.8 billion to $2.95 billion, with an effective tax rate of approximately 29%. GAAP fully diluted earnings per share are projected to be between $1.97 and $2.02, while Adjusted fully diluted earnings per share are anticipated to be in the range of $3.60 to $3.65. Adjusted EBITDA is forecasted to be between $450 million and $456 million.

Management Comments

  • "We are pleased with our third quarter results, which were largely in line with our expectations." Jerry Grisko, CBIZ President and CEO.
  • "Our core, recurring essential businesses continued to perform well, and improved market conditions also resulted in improved growth within our non-recurring businesses." Jerry Grisko, CBIZ President and CEO.
  • "We are seeing strong validation of the Marcum acquisition, including better than expected synergies, and are well positioned to drive sustainable long-term growth as we bring our unique value proposition to our clients and prospects in the high-growth U.S. middle market." Jerry Grisko, CBIZ President and CEO.

Industry Context

The results reflect strong performance in the professional services sector, particularly within the U.S. middle market, where CBIZ positions its 'unique value proposition.' The significant revenue growth is largely influenced by strategic acquisitions, such as Marcum, indicating a trend of consolidation and expansion in the advisory, accounting, and benefits industries. Improved market conditions are also noted as a driver for growth in non-recurring businesses, suggesting a favorable economic environment for professional services.

Legal Proceedings

  • A $12.5 million gain from a legal settlement payment from a small group of former employees was recorded during the nine months ended September 30, 2025.
  • Costs associated with this litigation were $1.1 million for the nine months ended September 30, 2025, and $1.3 million for the nine months ended September 30, 2024.
  • A $0.3 million adjustment to accrued legal costs associated with the $12.5 million legal settlement was recorded during the three months ended September 30, 2025.
  • Costs associated with this litigation were $0.5 million for the three months ended September 30, 2024.

Stakeholder Impact

  • Shareholders: Potential for long-term growth and increased shareholder value through strategic acquisitions and market positioning, but also risks from increased leverage, stock price volatility, and GAAP earnings decline.
  • Employees: Integration costs related to acquisitions include personnel costs, suggesting potential changes or restructuring. The deferred compensation plan is mentioned.
  • Clients: Company aims to deliver actionable insights and accelerate growth for middle-market businesses, leveraging expanded services from acquisitions like Marcum.
  • Creditors: Increased leverage and interest expense could impact credit risk perception, though the company has a $2.0 billion senior secured credit facility.

Next Steps

  • CBIZ hosted a conference call on October 29, 2025, at 5 p.m. (ET) to discuss its third quarter financial results.
  • An archived replay of the conference call will be available on the company's website.
  • The company plans to drive sustainable long-term growth by bringing its unique value proposition to clients and prospects in the high-growth U.S. middle market.

Key Dates

DateDescription
September 30, 2024End of the prior year's third quarter and nine-month period for comparison.
December 31, 2024End of the previous fiscal year, used for balance sheet comparisons.
September 30, 2025End of the third quarter and nine-month period for which financial results are reported.
October 29, 2025Date of Report (earliest event reported); CBIZ, Inc. issued a press release announcing financial results for Q3 and nine months ended September 30, 2025.
October 29, 2025Conference call held at 5 p.m. (ET) to discuss Q3 financial results.

Recommendation

hold

While CBIZ demonstrates impressive revenue and adjusted EBITDA growth, largely driven by the Marcum acquisition and "better than expected synergies," the decline in GAAP net income and EPS for the quarter, coupled with a substantial increase in interest expense and higher Days Sales Outstanding, presents a mixed financial picture. The increased leverage and debt-to-equity ratio also warrant caution. The company's strategic positioning in the middle market and recurring revenue streams are positive, but the GAAP performance and debt metrics suggest a "hold" position until there's clearer evidence of sustained GAAP profitability improvement and debt management post-acquisition integration.

Keywords

CBIZ, CBZ, Financial Results, Earnings, Q3 2025, Professional Services, Accounting, Tax, Advisory, Benefits, Insurance, Marcum Acquisition, EBITDA, EPS, Revenue Growth, Middle Market, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.